According to specialized media reports on July 22, 2026, a pioneering clinical trial in Australia would show that an eight-week swimming program combined with education could nearly halve disability from chronic lower back pain, with lasting benefits.
Just six weeks after the international health emergency declaration for the Bundibugyo Ebola strain, an unprecedented clinical trial began in Bunia, DRC, testing remdesivir and MBP134. With over 1,792 confirmed cases and 625 deaths as of July 9, 2026, the scientific community aims to reduce the mortality of a virus that kills one in three infected and has no approved vaccine or treatment.
El daraxonrasib, una píldora oral experimental, logró duplicar la supervivencia de pacientes con cáncer de páncreas metastásico en un ensayo clínico fase III presentado en ASCO Chicago. El medicamento bloquea mutaciones KRAS presentes en el 90% de los tumores pancreáticos, ofreciendo esperanza contra uno de los cánceres más mortales que existen.
Alfredo S. Quiroga
